SCHEMBL8554409

SCHEMBL8554409

CCCc1[nH]c2cc(C(=O)OC)cc(Cc3ccccc3Cl)c2c1C(=O)CCl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
PDE3B Q13370 1/20 0.44
PDE3A Q14432 1/20 0.44
ALOX5 P09917 2/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
ATM Q13315 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PPARG P37231 3/20 0.41
PPARA Q07869 3/20 0.41
PTGES O14684 1/20 0.38
GPR84 Q9NQS5 1/20 0.37
MAPT P10636 1/20 0.35
POLB P06746 1/20 0.35
SNCA P37840 1/20 0.35
KIF11 P52732 1/20 0.34
CNR1 P21554 1/20 0.34
HSP90AA1 P07900 1/20 0.34
HSP90B1 P14625 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8551585 0.90 SMN1; SMN2 (0.48) LMNASMN1; SMN2PDE3BPDE3AALOX5
SCHEMBL8555588 0.89 SMN1; SMN2 (0.47) LMNASMN1; SMN2PDE3BPDE3AALOX5
SCHEMBL8553605 0.82 ALOX5 (0.48) LMNASMN1; SMN2PDE3BPDE3AALOX5
SCHEMBL8551933 0.81 PDE3B (0.51) LMNASMN1; SMN2PDE3BPDE3AALOX5
SCHEMBL7424550 0.80 ALOX5 (0.39) LMNASMN1; SMN2PDE3BPDE3AALOX5
SCHEMBL251645 0.80 ALOX5 (0.43) LMNASMN1; SMN2PDE3BPDE3AALOX5
SCHEMBL8551838 0.77 LMNA (0.55) LMNASMN1; SMN2PDE3BPDE3AALOX5
SCHEMBL8557469 0.77 PDE3B (0.52) LMNASMN1; SMN2PDE3BPDE3AALOX5
SCHEMBL8554263 0.77 ALOX5 (0.39) LMNASMN1; SMN2PDE3BPDE3AALOX5
SCHEMBL8551861 0.77 ALOX5 (0.41) LMNASMN1; SMN2PDE3BPDE3AALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed